A descriptive analysis of hypertension and affiliated therapies in a military retiree population (ages 40-85 years) at Camp Lejeune, North Carolina

Military Medicine

Volumn 168, Issue 5, 2003, Pages 424-425

  Johnson, Bruce W ^a   Davies, William G ^b   Hardy, David W ^b   Varga, John ^c,d   Gallagher, Kevin L ^e   Ryan, Michael T ^f   Jones, R Martin ^g  

^a ALASKA NATIVE MEDICAL CENTER   (United States)

^b Dept of Defense Pharmacy Services ^*  (United States)

^c 3M Health Care   (United States)

^d CERNER CORPORATION   (United States)

^e Naval Hospital Camp Lejeune   (United States)

^f Health Physics Editorial Office   (United States)

^g MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FUROSEMIDE; HYDROCHLOROTHIAZIDE; LISINOPRIL; METOPROLOL; TRIAMTERENE; VERAPAMIL;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; GROUPS BY AGE; HEALTH CARE PLANNING; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MEDICAL INFORMATION SYSTEM; PENSIONER; POPULATION RESEARCH; PREVALENCE; STROKE; UNITED STATES;

EID: 0038300370     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.1093/milmed/168.5.424     Document Type: Article

References (4)

1. Brouker ME, Gallagher K, Larrat EP, Dufresne RL: Patient compliance and blood pressure control on a nuclear powered aircraft carrier: impact of a pharmacy officer. Milit Med 2000; 165: 106-10.
2. Hennessy BJ, Kerns DG, Davies WG: The incidence of active duty dental patients taking antihypertensive medications. Milit Med 1999: 164: 740-5.
3. Okano GJ, Rascati KL, Wilson JP, Remund DD, Grabenstein JD, Brixner DI: Patterns of antihypertensive use among patients in the U.S. Department of Defense database initially prescribed an angiotensin-converting enzyme inhibitor or calcium channel blocker. Clin Ther 1997; 19: 1435-45. discussion 1424-5.
4. National Committee for Quality Assurance: Controlling High Blood Pressure. HEDIS 2001 Technical Specifications 2000; 2: 75-8.